BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R, Mai F, Paoloni M, Ferri C, Desideri G, Cicogna S, Grassi D. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Sci Rep 2021;11:4863. [PMID: 33649408 DOI: 10.1038/s41598-021-83831-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Weber GM, Zhang HG, L'Yi S, Bonzel CL, Hong C, Avillach P, Gutiérrez-Sacristán A, Palmer NP, Tan ALM, Wang X, Yuan W, Gehlenborg N, Alloni A, Amendola DF, Bellasi A, Bellazzi R, Beraghi M, Bucalo M, Chiovato L, Cho K, Dagliati A, Estiri H, Follett RW, García Barrio N, Hanauer DA, Henderson DW, Ho YL, Holmes JH, Hutch MR, Kavuluru R, Kirchoff K, Klann JG, Krishnamurthy AK, Le TT, Liu M, Loh NHW, Lozano-Zahonero S, Luo Y, Maidlow S, Makoudjou A, Malovini A, Martins MR, Moal B, Morris M, Mowery DL, Murphy SN, Neuraz A, Ngiam KY, Okoshi MP, Omenn GS, Patel LP, Pedrera Jiménez M, Prudente RA, Samayamuthu MJ, Sanz Vidorreta FJ, Schriver ER, Schubert P, Serrano Balazote P, Tan BW, Tanni SE, Tibollo V, Visweswaran S, Wagholikar KB, Xia Z, Zöller D, Kohane IS, Cai T, South AM, Brat GA; Consortium For Clinical Characterization Of COVID-19 By EHR (4CE). International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study. J Med Internet Res 2021;23:e31400. [PMID: 34533459 DOI: 10.2196/31400] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Parimoo A, Biswas A, Baitha U, Gupta G, Pandey S, Ranjan P, Gupta V, Barman Roy D, Prakash B, Wig N. Dynamics of Inflammatory Markers in Predicting Mortality in COVID-19. Cureus 2021;13:e19080. [PMID: 34868744 DOI: 10.7759/cureus.19080] [Reference Citation Analysis]
3 Martínez-Salazar B, Holwerda M, Stüdle C, Piragyte I, Mercader N, Engelhardt B, Rieben R, Döring Y. COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences. Front Cell Dev Biol 2022;10:824851. [PMID: 35242762 DOI: 10.3389/fcell.2022.824851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Russo A, Gentilini Cacciola E, Borrazzo C, Filippi V, Bucci T, Vullo F, Celani L, Binetti E, Battistini L, Ceccarelli G, Alessandroni M, Galardo G, Mastroianni CM, d'Ettorre G. Clinical Characteristics and Outcome of Patients with Suspected COVID-19 in Emergency Department (RESILIENCY Study II). Diagnostics (Basel) 2021;11:1368. [PMID: 34441304 DOI: 10.3390/diagnostics11081368] [Reference Citation Analysis]
5 López-Martínez R, Albaiceta GM, Amado-Rodríguez L, Cuesta-Llavona E, Gómez J, García-Clemente M, Vázquez-Coto D, Alvarez V, Coto E. The FCGR2Ars1801274 polymorphism was associated with the risk of death among COVID-19 patients. Clin Immunol 2022;:108954. [PMID: 35149195 DOI: 10.1016/j.clim.2022.108954] [Reference Citation Analysis]
6 Kapoor B, Kochhar RS, Gulati M, Rani P, Gupta R, Kumar Singh S, Machawal L, Thakur A. Triumvirate to treat mucormycosis: Interplay of pH, metal ions and antifungal drugs. Medical Hypotheses 2022;159:110748. [DOI: 10.1016/j.mehy.2021.110748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
8 Kumar S, Rai N, Bansal A, Mittal A, Chandra NC. A Pilot Study on COVID-19 Positive Subjects: An Excerpt of Post-Infection-Pro-Diabetic Disposition & Related Consequences in Correlation to Hepato-Pancreatic Bio-Markers, Pro-Inflammatory Cytokines and Other Risk Factors. Indian J Clin Biochem 2022;:1-11. [PMID: 35756691 DOI: 10.1007/s12291-022-01054-8] [Reference Citation Analysis]
9 Korishettar G, Chikkahonnaiah P, Tulimilli SV, Dallavalasa S, Byrappa SH, Madhunapantula SV, Veeranna RP. Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients. Vaccines 2022;10:1125. [DOI: 10.3390/vaccines10071125] [Reference Citation Analysis]
10 Cham LB, Pahus MH, Grønhøj K, Olesen R, Ngo H, Monrad I, Kjolby M, Tolstrup M, Gunst JD, Søgaard OS. Effect of Age on Innate and Adaptive Immunity in Hospitalized COVID-19 Patients. J Clin Med 2021;10:4798. [PMID: 34682920 DOI: 10.3390/jcm10204798] [Reference Citation Analysis]
11 Carubbi F, Alunno A, Leone S, Di Gregorio N, Mancini B, Viscido A, Del Pinto R, Cicogna S, Grassi D, Ferri C. Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID? Viruses 2021;13:1997. [PMID: 34696427 DOI: 10.3390/v13101997] [Reference Citation Analysis]
12 Sen A, Nigam A, Vachher M. Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10366-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Bashir AM, Mukhtar MS, Mohamed YG, Cetinkaya O, Fiidow OA. Prevalence of Acute Kidney Injury in Covid-19 Patients- Retrospective Single-Center Study. IDR 2022;Volume 15:1555-60. [DOI: 10.2147/idr.s357997] [Reference Citation Analysis]
14 Mahan LD, Lill I, Halverson Q, Mohanka MR, Lawrence A, Joerns J, Bollineni S, Kaza V, La Hoz RM, Zhang S, Kershaw CD, Terada LS, Torres F, Banga A. Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation. Transpl Infect Dis 2021;:e13739. [PMID: 34605596 DOI: 10.1111/tid.13739] [Reference Citation Analysis]
15 Agwa SHA, Elghazaly H, Meteini MSE, Shawky SM, Ali M, Abd Elsamee AM, Sayed SM, Sherif N, Sharaf HM, Alhadidy MA, Matboli M. In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity. Cells 2021;10:3098. [PMID: 34831321 DOI: 10.3390/cells10113098] [Reference Citation Analysis]
16 Daniłowicz-Szymanowicz L, Świątczak M, Sikorska K, Starzyński RR, Raczak A, Lipiński P. Pathogenesis, Diagnosis, and Clinical Implications of Hereditary Hemochromatosis-The Cardiological Point of View. Diagnostics (Basel) 2021;11:1279. [PMID: 34359361 DOI: 10.3390/diagnostics11071279] [Reference Citation Analysis]
17 Kumar A, Weng I, Graglia S, Lew T, Gandhi K, Lalani F, Chia D, Duanmu Y, Jensen T, Lobo V, Nahn J, Iverson N, Rosenthal M, Gordon AJ, Kugler J. Point-of-Care Ultrasound Predicts Clinical Outcomes in Patients With COVID-19. J Ultrasound Med 2021. [PMID: 34468039 DOI: 10.1002/jum.15818] [Reference Citation Analysis]
18 Udut VV, Naumov SA, Udut EV, Naumov SS, Evtushenko DN, Chumakova ON, Zyuz'kov GN. Mechanisms of the Effects of Short-Term Inhalations of Xe and O2 Gas Mixture in the Rehabilitation of Post-COVID Ventilation Failure. Bull Exp Biol Med 2022;172:364-7. [PMID: 35001305 DOI: 10.1007/s10517-022-05393-7] [Reference Citation Analysis]
19 Asaduzzaman M, Nazmul Alam ZHM, Zabed Jillul Bari M, Jahangir Alam MM, Ranjan Chakraborty S, Ferdousi T. Clinical Characteristics and Predictors of Mortality in Elderly Patients Hospitalized with COVID-19 in Bangladesh: A Multicenter, Retrospective Study. Interdiscip Perspect Infect Dis 2022;2022:5904332. [PMID: 35698592 DOI: 10.1155/2022/5904332] [Reference Citation Analysis]
20 Ulgen A, Cetin S, Cetin M, Sivgin H, Li W. A Composite Ranking of Risk Factors for COVID-19 Time-To-Event Data from a Turkish Cohort. Computational Biology and Chemistry 2022. [DOI: 10.1016/j.compbiolchem.2022.107681] [Reference Citation Analysis]
21 Kumar DS, Hanumanram G, Suthakaran PK, Mohanan J, Nair LDV, Rajendran K. Extracellular Oxidative Stress Markers in COVID-19 Patients with Diabetes as Co-Morbidity. Clinics and Practice 2022;12:168-76. [DOI: 10.3390/clinpract12020021] [Reference Citation Analysis]
22 Shakaroun DA, Lazar MH, Horowitz JC, Jennings JH. Serum Ferritin as a Predictor of Outcomes in Hospitalized Patients with Covid-19 Pneumonia. J Intensive Care Med 2022;:8850666221113252. [PMID: 35815883 DOI: 10.1177/08850666221113252] [Reference Citation Analysis]
23 Serban D, Tribus LC, Vancea G, Stoian AP, Dascalu AM, Suceveanu AI, Tanasescu C, Costea AC, Tudosie MS, Tudor C, Gangura GA, Duta L, Costea DO. Acute Mesenteric Ischemia in COVID-19 Patients. J Clin Med 2021;11:200. [PMID: 35011941 DOI: 10.3390/jcm11010200] [Reference Citation Analysis]
24 Lee JX, Chieng WK, Abdul Jalal MI, Tan CE, Lau SCD. Role of Serum Ferritin in Predicting Outcomes of COVID-19 Infection Among Sickle Cell Disease Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2022;9:919159. [PMID: 35712092 DOI: 10.3389/fmed.2022.919159] [Reference Citation Analysis]
25 Singh V, Kamaleswaran R, Chalfin D, Buño-Soto A, San Roman J, Rojas-Kenney E, Molinaro R, von Sengbusch S, Hodjat P, Comaniciu D, Kamen A. A deep learning approach for predicting severity of COVID-19 patients using a parsimonious set of laboratory markers. iScience 2021;24:103523. [PMID: 34870131 DOI: 10.1016/j.isci.2021.103523] [Reference Citation Analysis]